Wikidata entity: Q415220
C₂₀H₂₁N₅O₆ (P274)
Quantities
| P2067 | mass | 427.149183 |
| P3780 | active ingredient in | ... | Q29004404 (Alimta) | Alimta |
| P3780 | active ingredient in | ... | Q29006325 (Pemetrexed Fresenius Kabi) | Pemetrexed Fresenius Kabi |
| P3780 | active ingredient in | ... | Q29006326 (Pemetrexed Hospira) | Pemetrexed Hospira |
| P3780 | active ingredient in | ... | Q29006327 (Pemetrexed Lilly) | Pemetrexed Lilly |
| P3780 | active ingredient in | ... | Q29006328 (Pemetrexed Medac) | Pemetrexed Medac |
| P790 | approved by | ... | Q204711 (Food and Drug Administration) | Food and Drug Administration |
| P233 | canonical SMILES | String | C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O | ??? |
| P373 | Commons category | String | Pemetrexed | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Pemetrexed%20ball-and-stick.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284878 (Լյարդի ախտահարման հավանականության E կատեգորիա) | Լյարդի ախտահարման հավանականության E կատեգորիա |
| P2175 | medical condition treated | ... | Q3658562 (non-small-cell lung carcinoma) | non-small-cell lung carcinoma |
| P2175 | medical condition treated | ... | Q18555143 (benign mesothelioma) | benign mesothelioma |
| P2175 | medical condition treated | ... | Q18556109 (bronchus carcinoma) | bronchus carcinoma |
| P2175 | medical condition treated | ... | Q18556653 (benign pleural mesothelioma) | benign pleural mesothelioma |
| P2175 | medical condition treated | ... | Q18557602 (malignant pleural mesothelioma) | malignant pleural mesothelioma |
| P129 | physically interacts with | ... | Q417149 (dihydrofolate reductase) | dihydrofolate reductase |
| P129 | physically interacts with | ... | Q14914198 (Phosphoribosylglycinamide formyltransferase) | Phosphoribosylglycinamide formyltransferase |
| P129 | physically interacts with | ... | Q22676802 (Thymidylate synthetase) | Thymidylate synthetase |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P3364 | stereoisomer of | ... | Q106029441 ((2R)-2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid) | (2R)-2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid |
| P9989 | stylized name | String | PEMEtrexed | ??? |
| P279 | subclass of | ... | Q27165478 (2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid) | 2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid |
| P2868 | subject has role | ... | Q127060 (folic acid) | folic acid |
| P2868 | subject has role | ... | Q2853144 (antineoplastic) | antineoplastic |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q7251505 (protein synthesis inhibitor) | protein synthesis inhibitor |
| P2868 | subject has role | ... | Q50573407 (folic acid antagonists) | folic acid antagonists |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | pemetrexed | ??? |
Why not click here or view trends?
log id: 2467489